Baker Chad R Has $8.52 Million Holdings in Relx Plc (NYSE:RELX)

Baker Chad R lifted its position in shares of Relx Plc (NYSE:RELX) by 50.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 169,025 shares of the technology company’s stock after buying an additional 56,575 shares during the quarter. Relx comprises about 1.7% of Baker Chad R’s holdings, making the stock its 26th largest position. Baker Chad R’s holdings in Relx were worth $8,521,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. LGT Group Foundation acquired a new stake in Relx in the fourth quarter worth $257,000. Paradigm Asset Management Co. LLC grew its holdings in Relx by 17.1% in the fourth quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company’s stock worth $3,706,000 after purchasing an additional 11,900 shares during the period. Smartleaf Asset Management LLC grew its holdings in Relx by 120.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company’s stock worth $548,000 after purchasing an additional 6,588 shares during the period. Public Employees Retirement System of Ohio grew its holdings in Relx by 21.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 162,830 shares of the technology company’s stock worth $7,396,000 after purchasing an additional 28,702 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Relx by 19.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company’s stock worth $6,517,000 after purchasing an additional 23,183 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

RELX has been the subject of a number of research reports. Morgan Stanley restated an “overweight” rating on shares of Relx in a report on Wednesday, April 16th. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. The Goldman Sachs Group assumed coverage on shares of Relx in a report on Wednesday, March 26th. They issued a “buy” rating for the company. Finally, Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy”.

Relx Stock Up 0.6%

Relx stock opened at $53.27 on Friday. Relx Plc has a 1-year low of $43.45 and a 1-year high of $56.33. The firm has a market capitalization of $98.33 billion, a price-to-earnings ratio of 28.64, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. The firm’s fifty day moving average price is $52.99 and its two-hundred day moving average price is $49.91. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.